Serastrands Biotherapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 415.33%
- Ebitda 649.71%
- Net Worth 59.13%
- Total Assets 63.54%
About Serastrands Biotherapeutics
Serastrands Biotherapeutics Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 September 2019 (Five years and four months 27 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sujatha Shrinivas and Natarajan Essakimuthu serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36994KA2019PTC128062
-
Company No.
128062
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Sep 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Serastrands Biotherapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujatha Shrinivas
|
Director | 18-Sep-2019 | Current |
|
Natarajan Essakimuthu
|
Director | 29-Oct-2019 | Current |
Financial Performance of Serastrands Biotherapeutics.
Serastrands Biotherapeutics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 415.33% increase in profit. The company's net worth Soared by an impressive increase of 59.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serastrands Biotherapeutics?
Unlock access to Serastrands Biotherapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Revenup Ai Technologies Private LimitedNatarajan Essakimuthu is a mutual person
-
Pollsem Agronomic Private LimitedSujatha Shrinivas is a mutual person
-
Sprygen Biotherapeutics Private LimitedSujatha Shrinivas and Natarajan Essakimuthu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Serastrands Biotherapeutics?
Unlock and access historical data on people associated with Serastrands Biotherapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serastrands Biotherapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serastrands Biotherapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
